Showing results (721-730 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|April 20, 2026
Deficiency of ZFP36L1 and ZFP36L2 impairs liver homeostasis and initiates cholestatic liver injuryRahul Kumar, Perry J Blackshear, Sonika Patial, et al.
Hepatology Communications|June 14, 2023
Standardizing liver imaging reporting and interpretation: LI-RADS and beyondNicole E Rich, Victoria Chernyak
Hepatology Communications|June 14, 2023
Management of alcohol use disorder in patients with chronic liver diseaseJessica L Mellinger, Anne C Fernandez, G Scott Winder
Hepatology Communications|June 14, 2023
A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinomaMaria Effenberger, Silvio Waschina, Christina Bronowski, et al.
Hepatology Communications|June 14, 2023
Rising alcohol-associated liver disease-related mortality rates in the United States from 1999 to 2022Fariha Ilyas, Hassam Ali, Pratik Patel, et al.
Hepatology Communications|June 2, 2023
Targets and study design for symptom-focused trials aimed at patients with cirrhosis: An expert consensusArpan A Patel, Elliot B Tapper, Fasiha Kanwal, et al.
Hepatology Communications|June 2, 2023
HBV screening among West Africans living in the US: Influences of stigma, health literacy, and self-efficacyPonni V Perumalswami, Assita Belemkoabga, Lovely Joseph, et al.
Hepatology Communications|May 22, 2026
A tailored pain self-management intervention for patients with cirrhosis is acceptable and improves pain controlShari S Rogal, Angela D Phares, Marilyn Brach, et al.
Hepatology Communications|May 22, 2026
Secretion of the HBV small surface antigen is driven by an ER autophagic pathwayHong Cao, Eugene Krueger, Jing Chen, et al.
Hepatology Communications|May 22, 2026
Midodrine versus placebo in patients with acute-on-chronic liver failure with ascites-A randomized trial (MIDAS trial)Anand V Kulkarni, Shantan Venishetty, Sridevi Prasanna, et al.
Pageof 179